{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:46:10Z","timestamp":1761821170151},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1978]]},"DOI":"10.1007\/bf00431840","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T06:51:51Z","timestamp":1100155911000},"page":"145-151","source":"Crossref","is-referenced-by-count":55,"title":["Effect of baclofen on tardive dyskinesia"],"prefix":"10.1007","volume":"56","author":[{"given":"J.","family":"Gerlach","sequence":"first","affiliation":[]},{"given":"T.","family":"Rye","sequence":"additional","affiliation":[]},{"given":"P.","family":"Kristjansen","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archpsyc.1973.01750340009001","volume":"28","author":"American College of Neuropsychopharmacology-Food and Drug Administration Task Force","year":"1973","unstructured":"American College of Neuropsychopharmacology-Food and Drug Administration Task Force: Neurological syndromes associated with antipsychotic drug use. Arch. Gen. Psychiatry 28, 463?467 (1973)","journal-title":"Arch. Gen. Psychiatry"},{"key":"CR2","doi-asserted-by":"crossref","unstructured":"And\u00e9n, N. E., Dal\u00e9n, P., Johansson, B.: Baclofen and lithium in Huntington's chorea. Lancet 1973II, 93","DOI":"10.1016\/S0140-6736(73)93285-6"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00502071","volume":"297","author":"N. E. And\u00e9n","year":"1973","unstructured":"And\u00e9n, N. E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 297, 89?92 (1973)","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0773.1977.tb02083.x","volume":"40","author":"N. E. And\u00e9n","year":"1977","unstructured":"And\u00e9n, N. E., Wachtel, H.: Biochemical effects of baclofen (?-parachlorophenyl-GABA) on the dopamine and the noradrenaline in the rat brain. Acta Pharmacol. Toxicol. (Kbh.) 40, 310?320 (1977)","journal-title":"Acta Pharmacol. Toxicol. (Kbh.)"},{"key":"CR5","first-page":"32","volume":"18","author":"F. J. Ayd Jr.","year":"1967","unstructured":"Ayd, F. J., Jr.: Persistent dyskinesia: a neurologic complication of major tranquilizers. Med. Sci. 18, 32?40 (1967)","journal-title":"Med. Sci."},{"key":"CR6","first-page":"497","volume-title":"GABA in nervous system function","author":"T. N. Chase","year":"1976","unstructured":"Chase, T. N., Walters, J. R.: Pharmacologic approach to the manipulation of GABA mediated synaptic function man. In: GABA in nervous system function. E. Roberts and T. N. Chase, eds., pp. 497?513. New York: Raven Press 1976"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0022-510X(75)90165-3","volume":"24","author":"L. E. Claveria","year":"1975","unstructured":"Claveria, L. E., Teychenne, P. F., Calne, D. B., Haskayne, L., Petrie, A., Pallis, C. A., Lodge-Patch, I. C.: Tardive dyskinesia treated with pimozide. J. Neurol. Sci. 24, 393?401 (1975)","journal-title":"J. Neurol. Sci."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0028-3908(76)90030-7","volume":"15","author":"B. Costall","year":"1976","unstructured":"Costall, B., Naylor, R. J., Pinder, R. M.: Mechanisms of dyskinesia in induction by 1-(3,4-dihydroxyphenyl) piperazine in the rat. Neuropharmacology 15, 203?210 (1976)","journal-title":"Neuropharmacology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1176\/ajp.124.8S.40","volume":"124","author":"G. E. Crane","year":"1968","unstructured":"Crane, G. E.: Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am. J. Psychiatry 124, 40?48 (1968)","journal-title":"Am. J. Psychiatry"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1192\/bjp.122.4.395","volume":"122","author":"G. E. Crane","year":"1973","unstructured":"Crane, G. E.: Persistent dyskinesia. Br. J. Psychiatry 122, 395?405 (1973)","journal-title":"Br. J. Psychiatry"},{"key":"CR11","doi-asserted-by":"crossref","unstructured":"Davis, K. L., Hollister, L. E., Berger, P. A.: Baclofen in schizophrenia. Lancet 1976I, 1245","DOI":"10.1016\/S0140-6736(76)92198-X"},{"key":"CR12","first-page":"177","volume":"53","author":"K. Fuxe","year":"1975","unstructured":"Fuxe, K., H\u00f6kfelt, T., Ljungdahl, \u00c5, Agnati, L., Johansson, O., de la Mora, M.: Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. Med. Biol. 53, 177?183 (1975)","journal-title":"Med. Biol."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00421217","volume":"34","author":"J. Gerlach","year":"1974","unstructured":"Gerlach, J., Reisby, N., Randrup, A.: Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia (Berl.) 34, 21?35 (1974)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000468206","volume":"11","author":"J. Gerlach","year":"1976","unstructured":"Gerlach, J., Thorsen, K.: The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment. Int. Pharmacopsychiatry 11, 1?7 (1976)","journal-title":"Int. Pharmacopsychiatry"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0447.1976.tb00122.x","volume":"54","author":"N. C. Gulman","year":"1976","unstructured":"Gulman, N. C., Bahr, B., Andersen, B., Eliassen, H. M.: A doubleblind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiatr. Scand 54, 287?293 (1976)","journal-title":"Acta Psychiatr. Scand"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0006-8993(73)90037-1","volume":"54","author":"T. Hattori","year":"1973","unstructured":"Hattori, T., McGeer, P. L., Fibiger, H. H., McGeer, E. G.: On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies. Brain Res. 54, 103?114 (1973)","journal-title":"Brain Res."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","volume":"21","author":"G. Honigfeld","year":"1965","unstructured":"Honigfeld, G., Klett, C. J.: The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophrenia. J. Clin. Psychol. 21, 65?71 (1965)","journal-title":"J. Clin. Psychol."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.1972.01750250081011","volume":"27","author":"H. Kazamatsuri","year":"1972","unstructured":"Kazamatsuri, H., Chien, C-p., Cole, J. O.: Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine. Arch. Gen. Psychiatry 27, 95?99 (1972a)","journal-title":"Arch. Gen. Psychiatry"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archpsyc.1972.01750250086012","volume":"27","author":"H. Kazamatsuri","year":"1972","unstructured":"Kazamatsuri, H., Chien, C-p., Cole, J. O.: Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate. Arch. Gen. Psychiatry 27, 100?103 (1972b)","journal-title":"Arch. Gen. Psychiatry"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0447.1976.tb00090.x","volume":"54","author":"S. Korsgaard","year":"1976","unstructured":"Korsgaard, S.: Baclofen (Lioresal\u00ae) in the treatment of neurolepticinduced tardive dyskinesia. Acta Psychiatr. Scand. 54, 17?24 (1976)","journal-title":"Acta Psychiatr. Scand."},{"key":"CR21","first-page":"31","volume":"7","author":"R. A. Lahti","year":"1974","unstructured":"Lahti, R. A., Losey, E. G.: Antagonism of the effects of chlorpromazine and morphine on dopamine metabolism by GABA. Res. Commun. Chem. Pathol. Pharmacol. 7, 31?40 (1974)","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1192\/bjp.129.2.114","volume":"129","author":"M. Linnoila","year":"1976","unstructured":"Linnoila, M., Viukari, M., Hietala, O.: Effects of sodium valproate on tardive dyskinesia. Br. J. Psychiatry 129, 114?119 (1976)","journal-title":"Br. J. Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-4886(75)90045-X","volume":"46","author":"G. M. McKenzie","year":"1975","unstructured":"McKenzie, G. M., Viik, K.: Chemically induced choreiform activity: antagonism by GABA and EEG patterns. Exp. Neurol. 46, 229?243 (1975)","journal-title":"Exp. Neurol."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0028-3908(76)90058-7","volume":"15","author":"S. R. Naik","year":"1976","unstructured":"Naik, S. R., Guidotto, A., Costa, E.: Central GABA receptor agonists: comparison of muscimol and baclofen. Neuropharmacology 15, 479?484 (1976)","journal-title":"Neuropharmacology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"J. E. Overall","year":"1962","unstructured":"Overall, J. E., Gorham, D. R.: The brief psychiatric rating scale. Psychol. Rep. 10, 799?812 (1962)","journal-title":"Psychol. Rep."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM197302152880703","volume":"228","author":"T. L. Perry","year":"1973","unstructured":"Perry, T. L., Hansen, S., Kloster, M.: Huntington's chorea: deficiency of ?-aminobutyric acid in brain. N. Engl. J. Med. 228, 337?342 (1973)","journal-title":"N. Engl. J. Med."},{"key":"CR27","doi-asserted-by":"crossref","unstructured":"Simpson, G. M., Branchey, M. H., Shrivastava, R. K.: Baclofen in schizophrenia. Lancet 1976I, 967?968","DOI":"10.1016\/S0140-6736(76)92749-5"},{"key":"CR28","doi-asserted-by":"crossref","unstructured":"Villeneuve, A., B\u00f6sz\u00f6rm\u00e9nyi, Z: Treatment of drug-induced dyskinesias. Lancet 1970I, 353?354","DOI":"10.1016\/S0140-6736(70)90724-5"},{"key":"CR29","first-page":"630","volume":"186","author":"J. R. Walters","year":"1973","unstructured":"Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigroneostriatal pathways. J. Pharmacol. Exp. Ther. 186, 630?639 (1973)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"CR30","first-page":"257","volume":"5","author":"D. D. Webster","year":"1968","unstructured":"Webster, D. D.: Critical analysis of the disability in Parkinson's disease. Mod. Treatment 5, 257?282 (1968)","journal-title":"Mod. Treatment"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1976.01770040061011","volume":"33","author":"J. W\u00e5linder","year":"1976","unstructured":"W\u00e5linder, J., Skott, A., Carlsson, A., Roos, B.-E.: Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. Arch. Gen. Psychiatry 33, 501?505 (1976)","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00431840\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T22:39:46Z","timestamp":1554849586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00431840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1978]]}},"alternative-id":["BF00431840"],"URL":"https:\/\/doi.org\/10.1007\/bf00431840","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978]]}}}